☆ 3.8 Article

RNA-seq and Single-Cell Transcriptome Analyses of TRAIL Receptors Gene Expression in Human Osteosarcoma Cells and Tissues

CANCER INFORMATICS (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

Single-cell RNA-seq identification of four differentially expressed survival-related genes by a TARGET: Osteosarcoma database analysis

Mesalie Feleke et al.

Summary: This study identified differentially expressed genes (DEGs) in osteosarcoma (OS) cells using single-cell RNA-sequencing data and determined the cell types that specifically express key DEGs. The findings highlight the heterogeneity of OS cells and the cell-type-dependent DEGs, which have potential as therapeutic targets in OS.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma

Mesalie Feleke et al.

Summary: This study examines the gene expression profile of pro-angiogenic factors in giant-cell tumor of bone (GCTB) and osteosarcoma (OS) using single-cell RNA sequencing data. The results show that the expression patterns of these genes are cell-type specific and may provide potential prognostic biomarkers and targeted treatment for GCTB and OS.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database

Emel Rothzerg et al.

Summary: The TARGET project aims to identify molecular changes driving childhood cancers, including osteosarcoma, and develop novel therapies by analyzing gene expression. A study identified 5758 differentially expressed genes between deceased and alive patients, with only 217 associated with overall survival. Eight downregulated genes and four upregulated genes were selected as potential independent prognostic candidate genes.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Add to Collection

Review Cell Biology

Current research progress in targeted anti-angiogenesis therapy for osteosarcoma

Yun Liu et al.

Summary: Osteosarcoma is the most common primary malignant bone tumor, with incidence peaking during adolescence. Despite improvements in prognosis with the introduction of neoadjuvant chemotherapy, outcomes have not significantly improved since then. Novel therapeutic strategies are urgently needed as an adjunct to conventional treatment modalities to improve outcomes for patients with osteosarcoma.

CELL PROLIFERATION (2021)

Add to Collection

Article Oncology

Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma

Yun Liu et al.

Summary: This study identified different cellular subtypes and key transcription factors associated with survival prognosis in osteosarcoma (OS) through single-cell RNA sequencing. Moreover, it revealed the mechanisms by which osteoblastic OS cells regulate osteolysis and angiogenesis, impacting survival prognosis. Furthermore, the study highlighted the potential of immunotherapy targeting CD8(+) T cells and macrophages for OS treatment.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Orthopedics

Survival of osteosarcoma patients following diagnosis of synchronous skip metastases

Peiming Yang et al.

JOURNAL OF ORTHOPAEDICS (2020)

Add to Collection

Review Oncology

Blood-borne biomarkers of osteosarcoma: A systematic review

Gerald J. S. Tan et al.

PEDIATRIC BLOOD & CANCER (2019)

Add to Collection

Article Surgery

Early Diagnosis: A Seeming Misfortune for Osteosarcoma of Mandible-Rare Case Report

Ashvin Wagh et al.

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

PET/CT in the diagnosis and prognosis of osteosarcoma

Xiaojuan Zhang et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2018)

Add to Collection

Review Oncology

PDGF/PDGFR effects in osteosarcoma and the add-on strategy

Jie Xu et al.

CLINICAL SARCOMA RESEARCH (2018)

Add to Collection

Article Oncology

Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs

Ying Huang et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

Add to Collection

Review Biotechnology & Applied Microbiology

Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data

Hai-Yong Ren et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Add to Collection

Article Biochemical Research Methods

The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex

Vidhyashankar Ramamurthy et al.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2015)

Add to Collection

Review Oncology

Review of the Molecular Pathogenesis of Osteosarcoma

Jin-Peng He et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Getting TRAIL back on track for cancer therapy

J. Lemke et al.

CELL DEATH AND DIFFERENTIATION (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Death receptor agonist therapies for cancer, which is the right TRAIL?

Pamela M. Holland

CYTOKINE & GROWTH FACTOR REVIEWS (2014)

Add to Collection

Review Oncology

Translational biology of osteosarcoma

Maya Kansara et al.

NATURE REVIEWS CANCER (2014)

Add to Collection

Article Oncology

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma

Marieke L. Kuijjer et al.

BMC CANCER (2013)

Add to Collection

Article Oncology

Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data

Marieke L. Kuijjer et al.

GENES CHROMOSOMES & CANCER (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling

Aurelie Rossin et al.

BIOCHEMICAL JOURNAL (2009)

Add to Collection

Letter Oncology

Barriers to effective TRAIL-targeted therapy of malignancy

Martin J. S. Dyer et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Add to Collection

Review Genetics & Heredity

Osteosarcoma (Osteogenic sarcoma)

Piero Picci

ORPHANET JOURNAL OF RARE DISEASES (2007)

Add to Collection

Review Genetics & Heredity

The promise of TRAIL - potential and risks of a novel anticancer therapy

Ronald Koschny et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2007)

Add to Collection

Article Endocrinology & Metabolism

Expression and function of TNF-family proteins and receptors in human osteoblasts

RF Bu et al.

BONE (2003)

Add to Collection

Article Oncology

Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy

S Bouralexis et al.

BRITISH JOURNAL OF CANCER (2003)

Add to Collection

Article Endocrinology & Metabolism

Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis

GJ Atkins et al.

BONE (2002)

Add to Collection

Article Oncology

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRIAL-induced apoptosis

A Evdokiou et al.

INTERNATIONAL JOURNAL OF CANCER (2002)

Add to Collection

Article Biochemistry & Molecular Biology

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

K Takeda et al.

NATURE MEDICINE (2001)

Add to Collection

Article Biochemistry & Molecular Biology

Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor

A Truneh et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.